JUST one new coronavirus cases has been confirmed in North Wales.

Public Health Wales figures released on Tuesday (May 11) show that Flintshire was the only county to register a new case.

This is the lowest number of new cases in the region since the start of the pandemic.

Flintshire's seven-day infection rate is now in single figures, while Wrexham's is only slightly higher at 12.5.

Sadly, one further death of someone who had tested positive for coronavirus in the last 28 days has been confirmed.

Over 850,000 people in Wales have had both doses of the vaccine, with nearly two million having received at least one dose.

Dr Giri Shankar, incident director for the Novel Coronavirus (Covid -19) outbreak response at Public Health Wales, said: “The variant B.1.617.2, one of the variants first identified in India, has been designated as a Variant of Concern (VOC21APR-02) due to its high transmissibility, which is comparable to the Kent variant.

"There is no evidence of wider community transmission of this variant in Wales, and the Kent variant remains the dominant strain here.

“Coronavirus cases by variant in Wales are reported on the UK Government website."

Dr Shankar added: "On Friday May 7, the Joint Committee on Vaccination and Immunisation (JCVI) updated its advice on the use of the COVID-19 Oxford/AstraZeneca vaccine for people aged under 40. JCVI advice is followed in Wales.

“The advice states that unvaccinated adults aged 30 - 39 years who are not in a clinical priority group because of long term health conditions, should where possible be offered an alternative to the AstraZeneca COVID-19 vaccine, where it would not significantly delay vaccination.

“JCVI is not advising against using AstraZeneca vaccine in 30-39 year olds, only that other vaccines are preferred. JCVI advise that anyone who has already received a first dose of AstraZeneca should continue to receive the same vaccine for their second dose, there are no clotting safety concerns with the second dose. It is the second dose which gives stronger and longer protection. Our statement in response to the latest advice is available to view on our website."